DEA Report: Counterfeit Controlled Prescription Drug Availability

The Drug Enforcement Administration (DEA) Philadelphia Field Division (PFD) is advising law enforcement and public health counterparts of the increased availability of counterfeit controlled prescription drugs (CPDs) – commonly sold as legitimate CPDs with most containing fentanyl/ fentanyl-related compounds (FRC) – in Pennsylvania and Delaware.

First observed as early as 2015, when they were acquired primarily through Dark Web suppliers, counterfeit CPDs have been seized with increasing frequency and quantity since that time, while several local production operations have also been identified and subsequently dismantled. Most recently, the increase in wholesale production and trafficking of counterfeit CPDs by Mexican transnational criminal organizations (TCOs) further demonstrates this emerging threat.

Access or download the report here


Our Partners

Pennsylvania Psychiatric Society
Pennsylvania Dental Association
DEA 360 Strategy
Pennsylvania District Attorneys Association
The Hospital and Healthsystem Association of Pennsylvania
Pennsylvania Pharmacists Association
Pennsylvania Medical Society